Darcy Banco, Rania Kanchi, Jasmin Divers, Samrachana Adhikari, Andrea Titus, Nichola Davis, Jenny Uguru, Parampreet Bakshi, Annie George, Lorna E Thorpe, John Dodson
{"title":"COVID-19大流行相关医疗中断对高血压控制的影响:对纽约市患有多种慢性疾病的老年人的回顾性分析","authors":"Darcy Banco, Rania Kanchi, Jasmin Divers, Samrachana Adhikari, Andrea Titus, Nichola Davis, Jenny Uguru, Parampreet Bakshi, Annie George, Lorna E Thorpe, John Dodson","doi":"10.1093/ajh/hpaf013","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Disruption of ambulatory healthcare in New York City (NYC) during the COVID-19 pandemic was common, but the impact on the cardiometabolic health of vulnerable patient groups is unknown. Therefore, we estimated the effect of total care disruption (TCD) on blood pressure (BP) control among older NYC residents with hypertension and at least one other chronic condition and examined whether neighborhood poverty moderated this impact.</p><p><strong>Methods: </strong>From the INSIGHT Clinical Research Network, we identified NYC residents ≥ 50 years of age with hypertension and at least one other chronic condition. TCD was defined as no ambulatory or telehealth visit during the pandemic. We contrasted the change in prevalence of controlled BP (BP < 140/90) before and after the pandemic among those with and without TCD via an inverse probability weighted (IPW) difference-in-difference regression model.</p><p><strong>Results: </strong>Among 212,673 eligible individuals, mean age was 69.5 years (SD: 10.2 years), and 15.1% experienced TCD. BP control declined from 52.4% to 45.9% among those with TCD and from 53.6% to 48.9% among those without TCD. After IPW adjustment, a larger decline in BP control was noted among those with TCD (adjusted difference-in-difference = 1.13 percentage points (95% CI: 0.32-1.94; P-value = 0.0058)). There was no consistent difference in the relationship between TCD and post-pandemic BP control across neighborhood poverty levels.</p><p><strong>Conclusion: </strong>COVID-19-related TCD was associated with a modest decline in BP control among older adults with hypertension in NYC; this was not moderated by neighborhood poverty level.</p>","PeriodicalId":7578,"journal":{"name":"American Journal of Hypertension","volume":" ","pages":"313-320"},"PeriodicalIF":3.1000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of COVID-19 Pandemic Related Healthcare Disruption on Hypertension Control: A Retrospective Analysis of Older Adults With Multiple Chronic Conditions in New York City.\",\"authors\":\"Darcy Banco, Rania Kanchi, Jasmin Divers, Samrachana Adhikari, Andrea Titus, Nichola Davis, Jenny Uguru, Parampreet Bakshi, Annie George, Lorna E Thorpe, John Dodson\",\"doi\":\"10.1093/ajh/hpaf013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Disruption of ambulatory healthcare in New York City (NYC) during the COVID-19 pandemic was common, but the impact on the cardiometabolic health of vulnerable patient groups is unknown. Therefore, we estimated the effect of total care disruption (TCD) on blood pressure (BP) control among older NYC residents with hypertension and at least one other chronic condition and examined whether neighborhood poverty moderated this impact.</p><p><strong>Methods: </strong>From the INSIGHT Clinical Research Network, we identified NYC residents ≥ 50 years of age with hypertension and at least one other chronic condition. TCD was defined as no ambulatory or telehealth visit during the pandemic. We contrasted the change in prevalence of controlled BP (BP < 140/90) before and after the pandemic among those with and without TCD via an inverse probability weighted (IPW) difference-in-difference regression model.</p><p><strong>Results: </strong>Among 212,673 eligible individuals, mean age was 69.5 years (SD: 10.2 years), and 15.1% experienced TCD. BP control declined from 52.4% to 45.9% among those with TCD and from 53.6% to 48.9% among those without TCD. After IPW adjustment, a larger decline in BP control was noted among those with TCD (adjusted difference-in-difference = 1.13 percentage points (95% CI: 0.32-1.94; P-value = 0.0058)). There was no consistent difference in the relationship between TCD and post-pandemic BP control across neighborhood poverty levels.</p><p><strong>Conclusion: </strong>COVID-19-related TCD was associated with a modest decline in BP control among older adults with hypertension in NYC; this was not moderated by neighborhood poverty level.</p>\",\"PeriodicalId\":7578,\"journal\":{\"name\":\"American Journal of Hypertension\",\"volume\":\" \",\"pages\":\"313-320\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ajh/hpaf013\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajh/hpaf013","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
背景:2019冠状病毒病(COVID-19)大流行期间,纽约市的门诊医疗中断很常见,但对弱势患者群体心脏代谢健康的影响尚不清楚。因此,我们估计了完全护理中断(TCD)对患有高血压和至少一种其他慢性疾病的纽约市老年居民血压(BP)控制的影响,并研究了社区贫困是否减缓了这种影响。方法:从INSIGHT临床研究网络中,我们确定了年龄≥50岁的患有高血压和至少一种其他慢性疾病的纽约市居民。TCD被定义为在大流行期间没有门诊或远程医疗访问。我们对比了控制性BP患病率的变化(BP结果:在212,673名符合条件的个体中,平均年龄为69.5岁(SD: 10.2岁),15.1%经历过TCD。有TCD组血压控制率从52.4%下降到45.9%,无TCD组从53.6%下降到48.9%。调整IPW后,TCD患者的血压控制下降幅度较大(调整差中差= 1.13个百分点(95% CI 0.32-1.94, p值=0.0058))。跨社区贫困水平的TCD与大流行后BP控制之间的关系没有一致性差异。结论:covid -19相关TCD与纽约市老年高血压患者血压控制适度下降有关;这并没有受到社区贫困水平的影响。
Effect of COVID-19 Pandemic Related Healthcare Disruption on Hypertension Control: A Retrospective Analysis of Older Adults With Multiple Chronic Conditions in New York City.
Background: Disruption of ambulatory healthcare in New York City (NYC) during the COVID-19 pandemic was common, but the impact on the cardiometabolic health of vulnerable patient groups is unknown. Therefore, we estimated the effect of total care disruption (TCD) on blood pressure (BP) control among older NYC residents with hypertension and at least one other chronic condition and examined whether neighborhood poverty moderated this impact.
Methods: From the INSIGHT Clinical Research Network, we identified NYC residents ≥ 50 years of age with hypertension and at least one other chronic condition. TCD was defined as no ambulatory or telehealth visit during the pandemic. We contrasted the change in prevalence of controlled BP (BP < 140/90) before and after the pandemic among those with and without TCD via an inverse probability weighted (IPW) difference-in-difference regression model.
Results: Among 212,673 eligible individuals, mean age was 69.5 years (SD: 10.2 years), and 15.1% experienced TCD. BP control declined from 52.4% to 45.9% among those with TCD and from 53.6% to 48.9% among those without TCD. After IPW adjustment, a larger decline in BP control was noted among those with TCD (adjusted difference-in-difference = 1.13 percentage points (95% CI: 0.32-1.94; P-value = 0.0058)). There was no consistent difference in the relationship between TCD and post-pandemic BP control across neighborhood poverty levels.
Conclusion: COVID-19-related TCD was associated with a modest decline in BP control among older adults with hypertension in NYC; this was not moderated by neighborhood poverty level.
期刊介绍:
The American Journal of Hypertension is a monthly, peer-reviewed journal that provides a forum for scientific inquiry of the highest standards in the field of hypertension and related cardiovascular disease. The journal publishes high-quality original research and review articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology.